Methodology

All entries for: Corvus Pharmaceuticals, Inc.

March 12, 2026

Corvus Pharmaceuticals, Inc.

Neutral Outlook

South San Francisco, CA
51-200 employees

For that and other reasons, it is currently unclear how the IRA will be effectuated.

Disease Area: Dermatology, Hematology, Immune Diseases, Oncology
Drug Type: Biologic, Small Molecule
Source
Source
Scroll to Top